Skip to main content
SpringerLink
Log in

Hodgkin and Non-Hodgkin lymphoma

  • Chapter
PET in Clinical Oncology

  • 152 Accesses

Abstract

The incidence of malignant lymphomas stands at about five new cases per 100 000 persons per year. These include instances both of Hodgkin’s disease (HD) and the heterogeneous group of non-Hodgkin lymphomas (NHL), with a relative frequency of about 1:3. Lymphomas originate from cells of the pul-pal tissue of the lymph nodes. Hodgkin’s lymphomas are characterized by a very small proportion of specific tumor cells (Hodgkin cells, Reed-Sternberg giant cells) surrounded by numerous nonneoplastic cells. This is distinct from the histological picture of NHL, whose pathognomonic cells constitute the main mass of the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmann DL, Kiely JM, Harrison EG et al. (1966) Malignant lymphoma of the spleen: a review of 49 cases in which the diagnosis was made at splenectomy. Cancer 19:461–469

    Article  PubMed  CAS  Google Scholar 

  2. Arita T, Kuramitsu T, Kawamura M et al. (1995) Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax 50:1267–1269

    Article  PubMed  CAS  Google Scholar 

  3. Bagley CM, Roth JA, Thomas LB et al. (1972) The liver biopsy in Hodgkin’s disease. Clinicopathologic correlation in 127 patients. Ann Int Med 76:219–225

    PubMed  Google Scholar 

  4. Bangerter M, Moog F (1998) Role of whole body FDG-PET in predicting relapse in residual masses after treatment of malignant lymphoma. Brit J Hematol 102 (abstr)

    Google Scholar 

  5. Bangerter M, Kotzerke J, Griesshammer M et al. (1999) PET with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma of the chest. Acta Oncol 38:799–804

    Article  PubMed  CAS  Google Scholar 

  6. Bengel FM, Ziegler S, Avril N et al. (1997) Whole body PET in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 24:1091–1098

    PubMed  CAS  Google Scholar 

  7. Braams JW, Pruim J, Freling NJM et al. (1995) Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36:211–216

    PubMed  CAS  Google Scholar 

  8. Braunstein EM, White SJ (1980) Non-Hodgkin lymphoma of bone. Radiology 135:5963

    Google Scholar 

  9. Bumann D, de Wit M, Beyer W et al. (1998) CT and F-18-FDG-PET in staging of malignant lymphoma. RöFo 168:457–465

    PubMed  CAS  Google Scholar 

  10. Carr R, Barrington SF, Madan B et al. (1998) Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91:3340–3346

    PubMed  CAS  Google Scholar 

  11. Castellino RA (1982) Imaging techniques for staging abdominal Hodgkin’s disease. Cancer Treat Rep 66:697–700

    PubMed  CAS  Google Scholar 

  12. Castellino RA (1992) Diagnostic imaging studies in patients with newly diagnosed Hodgkins disease. Annals of Oncology 3 (Suppl 4):45–47

    Article  PubMed  Google Scholar 

  13. Castellino RA, Blank N, Hoppe RT et al. (1986) Hodgkin’s disease: contribution of chest CT in the initial staging evaluation. Radiology 160:603–605

    PubMed  CAS  Google Scholar 

  14. Castellino RA, Hoppe R, Blank N et al. (1984) Computed tomography, lymphography, and staging laparatomy: correlations in initial staging of Hodgkin’s disease. AJR 143:37–41

    PubMed  CAS  Google Scholar 

  15. Coller BS, Chabner BA, Gralnick HR et al. (1977) Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphoma: observations on the value of bilateral biopsies. Am J Pathol 3:105–119

    CAS  Google Scholar 

  16. De Wit M, Bumann D, Beyer W et al. (1997) Whole-body PET for diagnosis of residual mass in patients with lymphoma. Ann Oncol 8 Suppl 1:57–60

    Google Scholar 

  17. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H et al. (1995) Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22:434–442

    Article  PubMed  CAS  Google Scholar 

  18. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H et al. (1997) Die Positronenemissionstomographie (PET) bei der Diagnostik and Therapieplanung von malignen Lymphomen. Radiologe 37:74–80

    Article  PubMed  CAS  Google Scholar 

  19. Dorfman RE, Alpern MB, Gross BH et al. (1991) Upper abdominal lymph node size determined with CT. Radiology 180:319–322

    PubMed  CAS  Google Scholar 

  20. Edeiken-Monroe B, Edeiken J, Kim E (1990) Radiologic concepts of lymphoma of bone. Radiol Clin North Am 28:841–864

    PubMed  CAS  Google Scholar 

  21. Eichhorn T, Schroeder HG, Glatz H et al. (1987) Histologisch kontrollierter Vergleich von Palpation and Sonographie bei der Diagnose von Halslymphknotenmetastasen. Laryngol Rhinol Otol 66:266–274

    CAS  Google Scholar 

  22. Einstein DM, Singer AA, Chilcote WA et al. (1991) Abdominal lymphadenopathy: spectrum of CT findings. RadioGraphics 11:457–472

    PubMed  CAS  Google Scholar 

  23. Ellis ME, Diehl LF, Granger E et al. (1989) Trephine needle bone marrow biopsy in the initial staging of Hodgkin’s disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Haematol 30:115–120

    CAS  Google Scholar 

  24. Ferrant A, Rodhain J, Michaux JL et al. (1975) Detection of skeletal involvement in Hodgkin’s disease: a comparison of radiography, bone scanning, and bone marrow biopsy in 38 patients. Cancer 35:1346–1353

    Article  PubMed  CAS  Google Scholar 

  25. Fishman EK, Kuhlman LE, Jones RJ et al. (1991) CT of lymphoma: spectrum of disease. RadioGraphics 11:647–669

    PubMed  CAS  Google Scholar 

  26. Glatz S, Kotzerke J, Moog F et al. (1996) Vortäuschung eines mediastinalen NonHodgkin-Lymphomrezidivs durch diffuse Thymushyperplasie. RöFo 165:309–310

    PubMed  CAS  Google Scholar 

  27. Gross BH, Glatzer GM, Orringer MB et al. (1988) Bronchogenic carcinoma metastatic to normal-sized nodes: frequency and significance. Radiology 166:71–74

    PubMed  CAS  Google Scholar 

  28. Higashi K, Clavo A, Wahl RL (1993) Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 34:414–419

    Google Scholar 

  29. Hoane BR, Shields AF, Porter BA et al. (1991) Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood 78:728–738

    PubMed  CAS  Google Scholar 

  30. Hoekstra O, Ossenkoppele GJ, Golding R et al. (1993) Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodesoxyglucose scintigraphy. J Nucl Med 34:1706–1710

    PubMed  CAS  Google Scholar 

  31. Hoffman JM, Waskin HA, Hanson MW et al. (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34:567–575

    PubMed  CAS  Google Scholar 

  32. Hoh CK, Glaspy J, Rosen P et al. (1997) Whole-body FDG-PET imaging for staging of Hodgkin’s disease and lymphoma. J Nucl Med 38:343–348

    PubMed  CAS  Google Scholar 

  33. Jabour BA, Choi Y, Hoh C et al. (1993) Extracranial head and neck: PET imaging with 2-(F18-)fluoro-2-deoxy-glucose and MR imaging correlation. Radiology 186:2735

    Google Scholar 

  34. Jánoskuti L, Szilvási I, Papp G et al. (1988) Bone scanning and radiography in the evaluation of patients with malignant lymphoma. Fortschr Röntgenstr 149:427–428

    Article  Google Scholar 

  35. Jones DN, McCovage GB, Sostman HD et al. (1996) Monitoring of neoadjuvant therapy response of soft-tissue and muskuloskeletal sarcoma using F-18-FDG. J Nucl Med 37:1438–1444

    PubMed  CAS  Google Scholar 

  36. Kaplan HS (1973) Staging laparatomy and splenectomy in Hodgkin’s disease: analysis of indications and patterns of involvement in 285 consecutive, unselected patients. Nat Canc Inst Monogr 36:291–298

    CAS  Google Scholar 

  37. Kaplan HS (1980) Hodgkin’s Disease, 2nd ed. Harvard University Press, Cambridge, MA

    Google Scholar 

  38. Kotzerke J, Guhlmann A, Moog F et al. (1998) Role of attenuation correction for FDG-PET in the primary staging of malignant lymphoma. Eur J Nucl Mecl (in press)

    Google Scholar 

  39. Kubota R, Yamada S, Ishiwata K et al. (1992) Intratumoral distribution of fluorine-18fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980

    PubMed  CAS  Google Scholar 

  40. Lapela M, Leskinen S, Minn H et al. (1995) Increased glucose metabolism in untreated non-Hodgkin’s lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 9:3522–3527

    Google Scholar 

  41. Larcos G, Farlow DC, Antico VF et al. (1994) The role of high dose 67-gallium scintigraphy in staging of untreated patients with lymphoma. Aust N Z J Med 29:5–8

    Article  Google Scholar 

  42. Leibenhaut MH, Hoppe RT, Efron B et al. (1989) Prognostic indicators of laparatomy findings in clinical stage III supradiaphragmatic Hodgkin’s disease. J Clin Oncol 7:81–91

    PubMed  CAS  Google Scholar 

  43. Leskinen-Kallio S, Ruotsalainen U, NAgren K et al. (1991) Uptake of carbon-llmethionine and fluorodeoxyglucose in non-Hodgkin’s lymphoma: a PET study. J Nucl Med 32:1211–1218

    PubMed  CAS  Google Scholar 

  44. Lowe VJ, Hoffman JM, DeLong DM et al. (1994) Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 35:1771–1777

    PubMed  CAS  Google Scholar 

  45. Mansfield C, Fabian C, Jones S et al. (1990) Comparison of lymphangiography and CT scanning in evaluating abdominal disease in stages III and IV Hodgkin’s disease. Cancer 66:2295–2299

    Article  PubMed  CAS  Google Scholar 

  46. McKenna RW, Hernandez JA (1988) Bone marrow in malignant lymphoma. Haematol/Oncol Clin North Am 2:617–635

    CAS  Google Scholar 

  47. Moog F, Bangerter M, Diederichs C et al. (1997) Lymphoma: role of whole-body FDG-PET in nodal staging. Radiology 203:795–800

    PubMed  CAS  Google Scholar 

  48. Moog F, Bangerter M, Diederichs C et al. (1998) Detection of extranodal malignant lymphoma with PET using FDG: comparison with computed tomography. Radiology 206:475–481

    PubMed  CAS  Google Scholar 

  49. Moog F, Bangerter M, Kotzerke J et al. (1998) FDG-PET as a new approach to detect lymphomatous bone marrow. J Clin Oncol 16:603–609

    PubMed  CAS  Google Scholar 

  50. Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413

    PubMed  CAS  Google Scholar 

  51. Munker R, Stengel A, Stäbler A et al. (1995) Diagnostic accuracy of US and CT in the staging of Hodgkin’s disease. 76:1460–1466

    CAS  Google Scholar 

  52. Newman JS, Francis IR, Kaminski MS et al. (1994) Imaging of lymphoma with PET with 2-(F-18)-fluoro-2-deoxy-d-glucose: correlation with CT. Radiology 190::111–116

    PubMed  CAS  Google Scholar 

  53. North LB, Fuller LM, Sullivan-Halley JA et al. (1987) Regression of mediastinal Hodgkin’s disease after therapy: evaluation of time interval. Radiology 164:599–602

    PubMed  CAS  Google Scholar 

  54. North LB, Fuller LM (1982) Importance of initial mediastinal adenopathy in Hodgkin’s disease. AJR 138:229–235

    PubMed  CAS  Google Scholar 

  55. O’Doherty MJ, Barrington SF, Campell M et al. (1997) PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38:1575–1583

    PubMed  Google Scholar 

  56. Okada J, Yoshikawa K, Imazeki K et al. (1992) Positron emission tomography using fluorine-18-fluorodeoxy-glucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med 33:325–329

    PubMed  CAS  Google Scholar 

  57. Okada J, Oonishi I, Yoshikawa K et al. (1994) FDG-PET for the evaluation of tumor viability after anticancer therapy. Ann Nucl Med 8:109–113

    Article  PubMed  CAS  Google Scholar 

  58. Orzel J, Sawaf NW, Richardson (1988) Lymphoma of the skeleton: scintigraphic evaluation. AJR 150:1095–1099

    PubMed  CAS  Google Scholar 

  59. Patz EF (1993) Focal pulmonary abnormalities: evaluation with F18-fluorodeoxyglucose PET scanning. Radiology 188:487–490

    PubMed  Google Scholar 

  60. Pendlebury SC, Koutts J, Boyages J et al. (1994) Hodgkin’s disease: clinical and radiological prognostic factors in a laparatomy series. Australasian Radiology 38:123–126

    Article  PubMed  CAS  Google Scholar 

  61. Pond GD, Castellino RA, Horning S et al. (1989) Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management. Radiology 170:159–164

    PubMed  CAS  Google Scholar 

  62. Radford JA, Cowan RA, Flanagan M et al. (1988) The significance of residual mediastinal abnormality on the chest radiography following radiation therapy for Hodgkin’s disease. J Clin Oncol 6:940–946

    PubMed  CAS  Google Scholar 

  63. Reske SN, Guhlmann A, Schirrmeister H et al (1998) PET in the diagnosis of abdominal tumors. Schweiz-Med-Wochenschr 128:96–108

    PubMed  CAS  Google Scholar 

  64. Rodriguez M (1998) CT, MRI, and PET in non-Hodgkin’s lymphoma. Acta Radiol Suppl 417:1–36

    PubMed  CAS  Google Scholar 

  65. Rodriguez M, Rehn S, Ahlström H et al. (1995) Predicting malignancy grade with PET in non-Hodgkin’s lymphoma. J Nucl Med 36:1790–1796

    PubMed  CAS  Google Scholar 

  66. Römer W, Hanauske AR, Ziegler S et al. (1998) PET in non-Hodgkin’s lymphoma: assessment of chemotherapy with FDG. Blood 91:4464 4471

    Google Scholar 

  67. Rosenberg SA, Berard CW, Brown BW et al. (1982) National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical use. Cancer 49:2112–2135

    Article  Google Scholar 

  68. Schechter JP, Jones SE, Woolfenden JM et al. (1976) Bone scanning in lymphoma. Cancer 38:1142–1146

    Article  PubMed  CAS  Google Scholar 

  69. Schirrmeister H (1998) Nachweis eines ossären Befalls beim Plasmozytom mit F-18FDG-PET. Nuklearmedizin 37:43–82 (abstr)

    Google Scholar 

  70. Shields AF, Porter BA, Churchley S et al. (1987) The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. J Clin Oncol 5:225–230

    PubMed  CAS  Google Scholar 

  71. Shreve PD, Grossman HB, Gross MD et al. (1996) Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-(F-18)fluoro-D-glucose. Radiology 199:751–756

    PubMed  CAS  Google Scholar 

  72. Skillings JR, Bramwell V, Nicholson RL et al. (1991) A prospective study of MRI in lymphoma staging. Cancer 67:1838–1843

    Article  PubMed  CAS  Google Scholar 

  73. Skovsgaard T, Brinckmeyer M, Vesterager L et al. (1982) The liver in Hodgkin’s disease-II. Histopathologic findings. Eur J Cancer Clin Oncol 18:429–435

    Article  PubMed  CAS  Google Scholar 

  74. Specht L (1992) Tumor burden as the main indicator of prognosis in Hodgkin’s disease. Eur J Cancer 12:1982–1985

    Article  Google Scholar 

  75. Taylor IK, Hill AA, Hayes M et al. (1996) Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography. Lancet 347:937–940

    Article  PubMed  CAS  Google Scholar 

  76. Tesoro-Tess JD, Balzarini L, Ceglia E et al. (1991) Magnetic resonance imaging in the initial staging of Hodgkin’s disease and non-Hodgkin lymphoma. Eur J Rad 12:81–90

    Article  CAS  Google Scholar 

  77. Thill R, Neuerburg J, Fabry U et al. (1997) Comparison of findings with F-18-FDG PET and CT in pretherapeutic staging of malignant lymphoma. Nuklearmedizin 36:234–239

    PubMed  CAS  Google Scholar 

  78. Vesselle HJ, Miraldi FD (1998) FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radio-Graphics 18:805–823

    CAS  Google Scholar 

  79. Villringer K, Jager H, Dichgans M et al. (1995) Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 19:532–536

    Article  CAS  Google Scholar 

  80. Wahl RL, Zasadny K, Helvie M et al. (1993) Metabolic monitoring of breast cancer chemohormonotherapy using PET: initial evaluation. J Clin Oncol 11:2101–2107

    CAS  Google Scholar 

  81. Weidmann E, Baican B, Hertel A et al. (1999) PET for staging and evaluation of response to treatment in patients with Hodgkin’s disease. Leuc and Lymph 34:545–551

    Google Scholar 

  82. Weissleder R, Elizondo G, Stark DD et al. (1989) The diagnosis of splenic lymphoma by MR imaging: value of supraparamagnetic iron oxide. AJR 152:175–180

    PubMed  CAS  Google Scholar 

  83. Widding A, Smolorz J, Franke M et al. (1989) Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases. J Nucl Med 15:230–238

    CAS  Google Scholar 

  84. Zasadny K, Wahl RL (1993) Standardized uptake values of normal tissues at PET with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 189:847–850

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. F. Moog
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bundeswehrzentralkrankenhaus Koblenz, Abteilung XV - Nuklearmedizin, Rübenacher Straße 170, Koblenz, 56072, Germany

    H. J. Wieler

  2. Division of Nuclear Medicine, Department of Radiology, DUMC 3949, Room 1419, Duke North Erwin Road, Durham, NC, 27710, USA

    R. Edward Coleman M.D. (Professor of Radiology, Vice-Chairman, Director) (Professor of Radiology, Vice-Chairman, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Moog, F. (2000). Hodgkin and Non-Hodgkin lymphoma. In: Wieler, H.J., Coleman, R.E. (eds) PET in Clinical Oncology. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57703-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57703-1_20

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63329-4

  • Online ISBN: 978-3-642-57703-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation